MedTrace Logo

A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003)

NCT06619665 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2024-10-01

No results posted yet for this study

Summary

This study examined the safety of the drug MK-6552 and if people tolerated it. It also studied whether MK-6552 works better than placebo for staying awake in sleep deprived healthy participants.

Conditions

Interventions

DRUG

MK-6552

MK-6552 gelatin coated capsules taken orally two times 8 hours apart

DRUG

MK-6552 placebo

MK-6552 placebo gelatin coated capsules taken orally two times 8 hours apart

DRUG

Modafinil

Modafinil tablet taken once orally

DRUG

Modafinil placebo

Modafinil placebo tablet taken once orally

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-19
Primary Completion
2024-07-16
Completion
2024-07-16
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06619665 on ClinicalTrials.gov